SPECIAL NOTICE
A -- DARPA and FDA Workshop on Preclinical Platforms for Evaluating Medical Countermeasure Efficacy and Toxicity - DARPA-SN-11-37
- Notice Date
- 5/20/2011
- Notice Type
- Special Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Other Defense Agencies, Defense Advanced Research Projects Agency, Contracts Management Office, 3701 North Fairfax Drive, Arlington, Virginia, 22203-1714
- ZIP Code
- 22203-1714
- Solicitation Number
- DARPA-SN-11-37
- Archive Date
- 6/30/2011
- Point of Contact
- Barry Pallotta,
- E-Mail Address
-
DARPA-SN-11-37@darpa.mil
(DARPA-SN-11-37@darpa.mil)
- Small Business Set-Aside
- N/A
- Description
- DARPA-SN-11-37 The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) and the U.S. Food and Drug Administration (FDA) Office of Chief Scientist (OCS) are hosting an informational workshop on June 21, 2011 at the Executive Conference Center (ECC) at Liberty Center in Arlington, VA. The purpose of the workshop is to discuss the scientific advancements that are needed, and the technical and regulatory challenges that must be overcome, for the development of human-relevant preclinical platforms for efficacy and toxicology testing. See attached DARPA-SN-11-37
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/ODA/DARPA/CMO/DARPA-SN-11-37/listing.html)
- Record
- SN02453937-W 20110522/110520235556-0ead71a0b4a631231ddd2abaeccec26f (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |